Clinical Evaluation of RoC Sun Protection Cream SPF44 in Photosensitive Diseases.
スポンサーリンク
概要
- 論文の詳細を見る
RoC Sun Protection Cream SPF44 (supplied by Johnson & Johnson K. K.) was applied to 33 photosensitive subjects who consulted with dermatologists between June 1 and Oct. 31, 1998. This sunscreen product obtains SPF44 and PA++ by dispersion agents and also contains ginkgo biloba and β-glucan (for the inhibition of free radical formation).<BR>The 4 and 8 week-tests results showed: 1) an improvement ratio of 69% (20 of 29 cases); 2) a ratio including moderately to remarkably improved cases of 96.6% (28 of 29 cases); and 3) an improvement ratio of 100% in cases with polymorphous light eruption. Moreover, there were no side effects in all cases. These results suggest that this sunscreen product could be applied with excellent efficacy and safety to photosensitive patients and also to healthy people to protect their skin from ultraviolet irradiation.
- 日本皮膚科学会大阪地方会の論文
日本皮膚科学会大阪地方会 | 論文
- ツベルクリン皮内反応部に出現する浸潤細胞の電顕的観察
- セフメタゾ-ル・ナトリウムによりSystemic eczematous contact-type dermatitis medicamentosaと急性腎不全を生じた1例 (単純化学物質による皮膚障害)
- 歯科金属アレルギ-による全身の扁平苔癬の1例 (接触皮膚炎とパッチテスト-4-)
- Oakmoss Allergyを示すPigmented Cosmetic Dermatitisの1例 (単純化学物質による皮膚障害)
- 漢方薬中のCinnamic系化合物による薬疹の1例 (単純化学物質による皮膚障害) -- (職業性および薬剤性皮膚炎と薬疹)